A reassessment of the PROPATRIA study and its implications for probiotic therapy

Ger P A Bongaerts1, René S V M Severijnen2

  • 1Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands.

Nature Biotechnology
|January 9, 2016
PubMed

Insights

The PROPATRIA trial found a higher mortality rate in severe acute pancreatitis patients receiving probiotics. This suggests a potential interaction between probiotics, pancreatic enzymes, and lactic acid, necessitating careful consideration in future research.

Area of Science:

  • Gastroenterology
  • Clinical Nutrition
  • Microbiology

Background:

  • Severe acute pancreatitis carries significant risks of infectious complications.
  • Enteral probiotics have been explored to mitigate these complications.
  • Previous studies suggested potential benefits of probiotics in related conditions.

Purpose of the Study:

  • To evaluate the efficacy of a multispecies probiotic preparation in reducing infectious complications in severe acute pancreatitis.
  • To investigate the safety and impact of probiotic therapy in this patient population.

Main Methods:

  • A multicenter, double-blind, placebo-controlled clinical trial (PROPATRIA).
  • Patients with predicted severe acute pancreatitis received either a probiotic preparation or placebo enterally.
  • Mortality rates and infectious complications were monitored.

Main Results:

  • The probiotic group experienced a significantly higher mortality rate (16%) compared to the placebo group (6%).
  • This contrasts with previous findings and suggests a potential adverse interaction.
  • Elevated lactic acid levels, possibly from bacterial fermentation, were implicated.

Conclusions:

  • Probiotic therapy in severe acute pancreatitis, as conducted in PROPATRIA, may be associated with increased mortality.
  • A lethal combination of pancreatic enzymes and probiotics, exacerbated by lactic acid, is hypothesized.
  • Future research should carefully consider timing, carbohydrate intake, bacterial overgrowth, and probiotic dosage.

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
144
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
529
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
46
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
29